Therapeutic approach to neurological manifestations of Angelman syndrome
Sign Up to like & getrecommendations! Published in 2022 at "Expert Review of Clinical Pharmacology"
DOI: 10.1080/17512433.2022.2109463
Abstract: ABSTRACT Introduction Angelman syndrome (AS) is a neurogenetic disorder due to deficient expression of the maternal copy of the UBE3A gene, which encodes ubiquitin ligase E3A protein. Severe developmental delay, seizures and other neurological disorders… read more here.
Keywords: manifestations angelman; approach neurological; neurological manifestations; therapeutic approach ... See more keywords